PC
TEVA icon

PointState Capital’s Teva Pharmaceuticals TEVA Stock Holding History

PointState Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,672,100
Closed -$115M – 69
2025
Q4 		$115M Hold
3,672,100
– – 1.96% 28
2025
Q3 		$74.2M Hold
3,672,100
– – 1.33% 32
2025
Q2 		$61.5M Hold
3,672,100
– – 1.32% 31
2025
Q1 		$56.4M Buy
3,672,100
+1,172,100
+47% +$20.9M 1.23% 35
2024
Q4 		$55.1M Hold
2,500,000
– – 1.25% 30
2024
Q3 		$45M Hold
2,500,000
– – 1.23% 28
2024
Q2 		$40.6M Buy
+2,500,000
New +$38.5M 1.16% 36
2016
Q4 		– Sell
-36,500
Closed -$1.68M – 165
2016
Q3 		$1.68M Buy
+36,500
New +$1.9M 0.02% 136

Other funds holding TEVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.04B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return